Pro Medicus (OTCMKTS:PMCUF) Trading 3.3% Higher – Here’s Why

Pro Medicus Limited (OTCMKTS:PMCUF)’s stock price rose 3.3% during trading on Friday . The stock traded as high as $92.95 and last traded at $87.85. Approximately 251 shares changed hands during mid-day trading, a decline of 67% from the average daily volume of 771 shares. The stock had previously closed at $85.01.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group set a $155.00 price target on shares of Pro Medicus and gave the stock a “buy” rating in a report on Thursday, February 12th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Pro Medicus currently has a consensus rating of “Buy” and a consensus price target of $155.00.

Pro Medicus Trading Up 3.3%

The stock’s fifty day simple moving average is $127.01 and its two-hundred day simple moving average is $164.45.

About Pro Medicus

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.